Trial Profile
Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Chronic limb-threatening ischemia
- Focus Therapeutic Use
- Acronyms STT-CLIPS
- 17 Jun 2019 Status changed from recruiting to completed.
- 16 May 2014 New trial record